2017
DOI: 10.1016/j.bspc.2017.06.008
|View full text |Cite
|
Sign up to set email alerts
|

Nonlinear adaptive control method for treatment of uncertain hepatitis B virus infection

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
12
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
5
3
1

Relationship

2
7

Authors

Journals

citations
Cited by 19 publications
(12 citation statements)
references
References 19 publications
0
12
0
Order By: Relevance
“…(19) and (21) for the Synergetic controller, by eqs. (34) and (43) for the Lyapunov Redesign controller and by the fuzzy rules for MT-FIS for treatment period of 90 days. The initial conditions at the start of the chronic stage of HCV for uninfected hepatocytes, infected hepatocytes and virions were x = [555 cells/ mL, 50, 000 cells/mL, 100, 000 cells/mL] T , respectively.…”
Section: Simulation Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…(19) and (21) for the Synergetic controller, by eqs. (34) and (43) for the Lyapunov Redesign controller and by the fuzzy rules for MT-FIS for treatment period of 90 days. The initial conditions at the start of the chronic stage of HCV for uninfected hepatocytes, infected hepatocytes and virions were x = [555 cells/ mL, 50, 000 cells/mL, 100, 000 cells/mL] T , respectively.…”
Section: Simulation Resultsmentioning
confidence: 99%
“…In the case of HCV treatment, the limitation of drug efficacy should be considered. Adaptive non‐linear controller has been proposed in [ 34 ] for the control of HBV infection. Practical limitations of treatment implementation, such as unavailability of states and efficacy limitations have not been considered in this work.…”
Section: Introductionmentioning
confidence: 99%
“…They determined the model parameters based on clinical information of past patients. Aghajanzadeh et al [23] suggested an adaptive control strategy for hepatitis B virus infection inside the human body by antiviral drugs. They considered model parameters uncertainties on model parameters and employed adaptive controller to control the dynamic despite uncertainties of the system.…”
Section: Related Research Workmentioning
confidence: 99%
“…For instance, Moradi et al [32, 33] have suggested adaptive robust controllers for the cancer chemotherapy to manipulate the drug usage and consequently the tumour volume. A non‐linear adaptive control scheme has been also designed for the treatment of uncertain hepatitis B virus infection by Aghajanzadeh et al [34]. Another adaptive controller and feedback error learning has been presented by Rouhollahi et al [35] for rehabilitation therapy in Parkinson's disease.…”
Section: Introductionmentioning
confidence: 99%